Utah Health & Economic Recovery Outreach (HERO) is a massive undertaking that has tested more than 13,000 Utahns to date across multiple counties in Utah to gather data to more accurately establish the rate of COVID-19 infection in Utah, and rates of infection in various age groups and job categories. In Phase One of Utah HERO, data were gathered from households in Utah, Davis, Salt Lake, and Summit counties. Phase Two has extended to other areas in Utah including Washington County, where participants were contacted by mail, and west Salt Lake City, where there is concern over heightened viral activity.
The data collected in Utah HERO will help indicate where COVID-19 has spread, which groups are most impacted, and how many undetected infections are occurring. This information will help guide state decision-makers, health professionals, and business leaders as Utah navigates through the COVID-19 pandemic.
How to Participate
Utah HERO team members will knock on doors in neighborhoods to introduce the project and screen household members for eligibility while adhering to current social distancing and hygiene recommendations from the Centers for Disease Control and Prevention and local health agencies.
Utah HERO relies on scientific sampling in order to understand what is happening in Utah communities.
Testing Process
Utah HERO Test Results
Email the Utah HERO team at utcovid19project@utah.edu for any questions related to testing.
Phase One Briefing
Phase one of the two-phase project aims to measure the proportion of people who have antibody to the virus that causes COVID-19 infection, in order to understand prevalence within the population (the total number of infections that have occurred over time) and other factors associated with the virus.
Phase One Findings
Phase Two
Phase Two will extend the same work to Utah's other counties, assess communities that may have high viral activity, focus on students/children to help guide best practices for returning to school, and monitor changes in antibody prevalence over time.